Keyphrases
Cell Growth
100%
ErbB2
100%
Apoptosis
100%
Small Bowel Adenocarcinoma
100%
Small Interfering RNA (siRNA)
37%
Cell Viability
25%
Upper Gastrointestinal Tract
25%
Knockdown
25%
Adenocarcinoma Cells
25%
ERBB2 Amplification
25%
In Cancer
12%
Targeted Therapy
12%
Treatment Strategy
12%
Breast
12%
Apoptotic Pathway
12%
Adenocarcinoma
12%
Direct Therapy
12%
Protein Level
12%
Overall Survival
12%
Disease-free
12%
Cell Apoptosis
12%
Gastroesophageal Junction
12%
Gastric Cancer Cell Lines
12%
OE19
12%
ERBB2 Protein
12%
MKN45
12%
Cell Changes
12%
Esophageal Cancer Cell Line
12%
Medicine and Dentistry
Cell Growth
100%
Programmed Cell Death
100%
Gastrointestinal Carcinoma
100%
Small Interfering RNA
60%
Cell Viability
40%
Adenocarcinoma Cell Line
40%
Malignant Neoplasm
20%
Disease
20%
Cell Cycle
20%
Targeted Therapy
20%
Adenocarcinoma
20%
Overall Survival
20%
Gastric Cancer Cell Line
20%
Gastroesophageal Junction
20%
Esophageal Cancer Cell Line
20%
Cell Line
20%
Pharmacology, Toxicology and Pharmaceutical Science
Gastrointestinal Carcinoma
100%
Small Interfering RNA
60%
Cell Viability
40%
Malignant Neoplasm
20%
Esophagus Cancer
20%
Overall Survival
20%
Abdominal Cancer
20%
Disease
20%
Adenocarcinoma
20%